Thibault Jacques Dit Lapierre received his Master’s degree in Chemistry of Biomolecules – Research & Innovation from the École Nationale Supérieure de Chimie de Montpellier (ENSCM, Montpellier, France) in 2020. His Master’s research was carried out at the Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (Leibniz-HKI) in Jena, Germany, where he focused on optimising the synthesis of antitubercular nitrobenzothiazinone derivatives and synthesising new A-ring derivatives of the same class, under the supervision of Dr. Florian Kloss. Following his M. Sc., he pursued his Ph. D. in Medicinal Chemistry at the Federal University of Uberlândia (UFU, Uberlândia, Brazil) under the supervision of Prof. Dr. Celso de Oliveira Rezende Júnior, which he received in 2025. His doctoral research involved the hit-to-lead optimisation of a series of pyrazinylpiperazine derivatives and a series of 2-ethyl-4-phenylthiazoles against visceral leishmaniasis and Chagas disease, focusing on the design and synthesis of new analogues within each class. In 2026, he joined the Medicinal Chemistry unit of Rega Institute as a postdoctoral researcher, under the supervision of Prof. Dr. Peter Verwilst.